Olsalazine was not better than placebo in maintaining remission in inactive Crohn disease.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/FEC75AD5.svg?ark=w1%2F20260515%2FFEC75AD5)](https://nobleid.org/work/w1/20260515/FEC75AD5)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors